These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27027879)

  • 1. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 1).
    Wilson AJ; Gunning PT
    Chembiochem; 2016 Apr; 17(8):644-5. PubMed ID: 27027879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 2).
    Wilson AJ; Gunning PT
    ChemMedChem; 2016 Apr; 11(8):732-3. PubMed ID: 27061459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Interfaces as Targets in Drug Discovery.
    Fattorusso C; Persico M
    Curr Top Med Chem; 2015; 15(20):2003-4. PubMed ID: 26156196
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial special issue on "Quantum Mechanics in Industry".
    Göller AH
    J Comput Aided Mol Des; 2021 Apr; 35(4):397-398. PubMed ID: 33586061
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery.
    Arntson KE; Pomerantz WC
    J Med Chem; 2016 Jun; 59(11):5158-71. PubMed ID: 26599421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Protein-Protein Interactions for the Development of Effective Therapeutics - From a Joint Perspective of Experiment and Computation.
    Moreira IS; Sensoy O
    Curr Top Med Chem; 2018; 18(8):645-646. PubMed ID: 30062954
    [No Abstract]   [Full Text] [Related]  

  • 7. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling human Src homology 2 (SH2) domain proteins and ligand discovery using a peptide-hybrid small molecule microarray.
    Fu J; Na Z; Uttamchandani M; Yao SQ
    Chem Commun (Camb); 2013 Oct; 49(83):9660-2. PubMed ID: 24022784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer space exploration: an assessment of dendrimers/dendritic scaffolding as inhibitors of protein-protein interactions, a potential new area of pharmaceutical development.
    Mignani S; El Kazzouli S; Bousmina MM; Majoral JP
    Chem Rev; 2014 Jan; 114(2):1327-42. PubMed ID: 24127777
    [No Abstract]   [Full Text] [Related]  

  • 13. New Modalities for Challenging Targets in Drug Discovery.
    Valeur E; Guéret SM; Adihou H; Gopalakrishnan R; Lemurell M; Waldmann H; Grossmann TN; Plowright AT
    Angew Chem Int Ed Engl; 2017 Aug; 56(35):10294-10323. PubMed ID: 28186380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting protein-protein interactions for drug discovery.
    Fry DC
    Methods Mol Biol; 2015; 1278():93-106. PubMed ID: 25859945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbiased binding assays for discovering small-molecule probes and drugs.
    Kemp MM; Weïwer M; Koehler AN
    Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of small molecule inhibitors of protein-protein interactions using combined ligand and target score normalization.
    Casey FP; Pihan E; Shields DC
    J Chem Inf Model; 2009 Dec; 49(12):2708-17. PubMed ID: 19994847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stacking Interactions of Heterocyclic Drug Fragments with Protein Amide Backbones.
    Bootsma AN; Wheeler SE
    ChemMedChem; 2018 Apr; 13(8):835-841. PubMed ID: 29451739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial synthetic receptors as regulators of protein activity.
    Dutt S; Wilch C; Schrader T
    Chem Commun (Camb); 2011 May; 47(19):5376-83. PubMed ID: 21394349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of DNA-encoded small molecule libraries against unmodified and non-immobilized protein targets.
    Zhao P; Chen Z; Li Y; Sun D; Gao Y; Huang Y; Li X
    Angew Chem Int Ed Engl; 2014 Sep; 53(38):10056-9. PubMed ID: 25044298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.